Ranked #6,502 of 8,699 institutional investors
Sivik Global Healthcare LLC
Greenwich, CT
$178M
US stock portfolio at live prices · today −$566K (−0.32%)
Live prices, last trade 12:46 PM ET
- Value at quarter end (Q3 2026)
- $175M
- Change from Q2 2026
- +$35.6M (+25.51%)
- Positions
- 34 · 11 new, 9 sold out
- Filed
- Oct 13, 2026
Not counted in the ranking: none$3.9M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesXBI 14.3%MCK 3.96%HUM 3.94%CAH 3.87%JNJ 3.65%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| XBI State Street SPDR S&P Biotech ETF | 180,000 | $25.5M | 14.3% | Added +20% |
| MCK McKesson Corporation | 6,500 | $7.0M | 3.96% | Added +63% |
| HUM Humana Inc. | 17,700 | $7.0M | 3.94% | Reduced −12% |
| CAH Cardinal Health, Inc. | 25,000 | $6.9M | 3.87% | Added +4% |
| JNJ Johnson & Johnson | 24,000 | $6.5M | 3.65% | Added +20% |
| ABBV AbbVie Inc. | 22,000 | $6.3M | 3.57% | Added +47% |
| COR Cencora, Inc. | 18,000 | $6.2M | 3.47% | Added +20% |
| TMO Thermo Fisher Scientific Inc. | 8,500 | $5.7M | 3.22% | Added +6% |
| LLY Eli Lilly and Company | 4,230 | $5.7M | 3.22% | Reduced −15% |
| ABT Abbott Laboratories | 55,000 | $5.7M | 3.22% | Added +120% |
| ELV Elevance Health, Inc. | 14,000 | $5.6M | 3.17% | Added +180% |
| DHR Danaher Corporation | 25,000 | $5.5M | 3.12% | Added +25% |
| VRTX Vertex Pharmaceuticals Incorporated | 10,500 | $5.5M | 3.08% | Added +5% |
| MRK Merck & Co., Inc. | 40,000 | $5.4M | 3.02% | Unchanged |
| EHC Encompass Health Corporation | 40,000 | $5.4M | 3.02% | Added +167% |
| CNC Centene Corporation | 80,000 | $5.2M | 2.92% | New |
| UNH UnitedHealth Group Incorporated | 15,000 | $5.2M | 2.90% | Added +50% |
| A Agilent Technologies, Inc. | 30,000 | $5.1M | 2.87% | Unchanged |
| EW Edwards Lifesciences Corporation | 45,000 | $4.6M | 2.61% | Added +125% |
| WAT Waters Corporation | 10,000 | $4.4M | 2.49% | Reduced −33% |
| RVTY Revvity, Inc. | 30,000 | $4.4M | 2.46% | New |
| GILD Gilead Sciences, Inc. | 25,000 | $4.2M | 2.37% | Unchanged |
| MTD Mettler-Toledo International Inc. | 2,500 | $4.2M | 2.36% | Reduced −9% |
| BRKR Bruker Corporation | 65,000 | $3.7M | 2.10% | New |
| BIIB Biogen Inc. | 15,000 | $3.7M | 2.10% | Unchanged |
| CI The Cigna Group | 13,203 | $3.7M | 2.06% | New |
| RGEN Repligen Corporation | 20,000 | $3.3M | 1.85% | New |
| BIO Bio-Rad Laboratories, Inc. | 8,000 | $2.9M | 1.62% | Reduced −20% |
| AVTR Avantor, Inc. | 175,000 | $2.6M | 1.49% | New |
| MRNA Moderna, Inc. | 10,000 | $2.0M | 1.10% | New |
| ARGX argenx SE | 2,000 | $1.9M | 1.06% | New |
| BNTX BioNTech SE | 22,000 | $1.8M | 1.00% | New |
| MDGL Madrigal Pharmaceuticals, Inc. | 2,500 | $972K | 0.55% | New |
| TWST Twist Bioscience Corporation | 1,128 | $118K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| THC Tenet Healthcare Corporation | 20,000 | $5.3M |
| REGN Regeneron Pharmaceuticals, Inc. | 4,000 | $3.7M |
| ISRG Intuitive Surgical, Inc. | 9,000 | $3.6M |
| SYK Stryker Corporation | 10,000 | $3.1M |
| UHS Universal Health Services, Inc. | 17,500 | $3.1M |
| BSX Boston Scientific Corporation | 62,000 | $2.6M |
| GMED Globus Medical, Inc. | 30,000 | $2.0M |
| CVS CVS Health Corporation | 20,000 | $1.6M |
| SNN Smith & Nephew plc | 50,000 | $1.5M |